Exicure (XCUR) Cash & Equivalents (2016 - 2026)
Exicure (XCUR) posted Cash & Equivalents of $1.72 million for Q2 2026, down 78.1% from $7.86 million a year earlier and down 34.1% from the prior quarter.
Powered by 
Analysis
Exicure (XCUR) Cash & Equivalents (2016 - 2026) Analysis & Trends
At the end of FY2025, Exicure's Cash & Equivalents came in at $3.75 million, down 70.1% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -35.4% (FY2020 to FY2025).
- In prior years, Exicure's Cash & Equivalents was $12.51 million in FY2024 (+520.4%), $2.02 million in FY2023 (-79.4%), $9.78 million in FY2022 (-71.8%) and $34.64 million in FY2021 (+4.2%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents since Q3 2024.
- On a year-over-year basis, Cash & Equivalents has declined in each of the last three quarters, with growth averaging 46.9% over the last five quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2024, with growth of 520.4%; the weakest was Q1 2024, with a decline of 96.3%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $2.6 million (Q1 2026), $3.75 million (Q4 2025) and $4.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Exicure | 7.39 Mn | 7.39 Mn | - | 1.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.72 Mn |
| Mar 31, 2026 | 2.60 Mn |
| Dec 31, 2025 | 3.75 Mn |
| Sep 30, 2025 | 4.44 Mn |
| Jun 30, 2025 | 7.86 Mn |
| Mar 31, 2025 | 10.42 Mn |
| Dec 31, 2024 | 12.51 Mn |
| Sep 30, 2024 | 343,000.00 |
| Jun 30, 2024 | 528,000.00 |
| Mar 31, 2024 | 366,000.00 |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | 922,000.00 |
| Jun 30, 2023 | 2.34 Mn |
| Mar 31, 2023 | 9.96 Mn |
| Dec 31, 2022 | 9.78 Mn |
| Sep 30, 2022 | 15.65 Mn |
| Jun 30, 2022 | 21.20 Mn |
| Mar 31, 2022 | 23.89 Mn |
| Dec 31, 2021 | 34.64 Mn |
| Sep 30, 2021 | 51.89 Mn |
API Access
Exicure Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=XCUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "XCUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=XCUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();